|
Araujo, Fausto G; Slifer, Teri (2003) Different strains of Toxoplasma gondii induce different cytokine responses in CBA/Ca mice. Infect Immun 71:4171-4
|
|
Yardley, Vanessa; Khan, Anis A; Martin, Michael B et al. (2002) In vivo activities of farnesyl pyrophosphate synthase inhibitors against Leishmania donovani and Toxoplasma gondii. Antimicrob Agents Chemother 46:929-31
|
|
Khan, A A; Lambert Jr, L H; Remington, J S et al. (1999) Recombinant bactericidal/permeability-increasing protein (rBPI21) in combination with sulfadiazine is active against Toxoplasma gondii. Antimicrob Agents Chemother 43:758-62
|
|
Khan, A A; Araujo, F G; Brighty, K E et al. (1999) Anti-Toxoplasma gondii activities and structure-activity relationships of novel fluoroquinolones related to trovafloxacin. Antimicrob Agents Chemother 43:1783-7
|
|
Khan, A A; Slifer, T R; Araujo, F G et al. (1999) Quinupristin-dalfopristin is active against Toxoplasma gondii. Antimicrob Agents Chemother 43:2043-5
|
|
Khan, A A; Slifer, T R; Araujo, F G et al. (1999) Effect of clarithromycin and azithromycin on production of cytokines by human monocytes. Int J Antimicrob Agents 11:121-32
|
|
Araujo, F G; Khan, A A; Bryskier, A et al. (1998) Use of ketolides in combination with other drugs to treat experimental toxoplasmosis. J Antimicrob Chemother 42:665-7
|
|
Khan, A A; Slifer, T R; Remington, J S (1998) Effect of trovafloxacin on production of cytokines by human monocytes. Antimicrob Agents Chemother 42:1713-7
|
|
Khan, A A; Nasr, M; Araujo, F G (1998) Two 2-hydroxy-3-alkyl-1,4-naphthoquinones with in vitro and in vivo activities against Toxoplasma gondii. Antimicrob Agents Chemother 42:2284-9
|
